PLIAZON Trademark

Trademark Overview

On Tuesday, April 6, 2004, a trademark application was filed for PLIAZON with the United States Patent and Trademark Office. The USPTO has given the PLIAZON trademark a serial number of 79003254. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, April 6, 2014. This trademark is owned by Merck KGaA. The PLIAZON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of cancer
pliazon

General Information

Serial Number79003254
Word MarkPLIAZON
Filing DateTuesday, April 6, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, April 6, 2014
Registration Number3023875
Registration DateTuesday, December 6, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, November 7, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, October 30, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, October 30, 2014DEATH OF INTERNATIONAL REGISTRATION
Thursday, July 17, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, April 30, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 30, 2013CANCELLED SECTION 71
Friday, September 28, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 27, 2006FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 27, 2006FINAL DISPOSITION PROCESSED
Sunday, July 16, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 6, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, September 13, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2005NOTICE OF PUBLICATION
Friday, July 29, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 18, 2005ASSIGNED TO LIE
Friday, April 15, 2005ASSIGNED TO LIE
Thursday, April 14, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, March 17, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 17, 2005PAPER RECEIVED
Thursday, December 23, 2004REFUSAL PROCESSED BY IB
Thursday, November 18, 2004NON-FINAL ACTION MAILED
Tuesday, November 9, 2004NON-FINAL ACTION WRITTEN
Wednesday, October 27, 2004ASSIGNED TO EXAMINER
Monday, July 19, 2004NEW APPLICATION ENTERED IN TRAM
Thursday, July 15, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pliazon treatment cancer prevention human preparations pharmaceutical